articleThe LancetJan 1, 2005Closed access

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer

AHAnthony HowellJCJack CuzickMBM BaumABA. BuzdarMDMitch Dowsett

The Christie Hospital

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

2,280
total citations
FWCI
146.43
Percentile
100%
References
5
Citations per year

Authors

11

Topics & keywords

Topics
Keywords
  • Anastrozole
  • Tamoxifen
  • Medicine
  • Breast cancer
  • Hazard ratio
  • Aromatase inhibitor
  • Internal medicine
  • Oncology
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.